CircRNA EIF6-224aa directly interacts with the MYH9 protein and impedes MYH9 degradation by suppressing the ubiquitin-proteasome pathway, subsequently activating the Wnt/beta-catenin signalling pathway in triple-negative breast cancer [53]. Here, MYH9 is linked to triple-negative breast carcinoma.